Find Academic Supervisors

Dr. Regina Y. Baker is a Clinical Associate Professor of Surgery in the Division of Plastic and Reconstructive Surgery at the Keck School of Medicine of USC. She holds faculty positions at USC University Hospital, USC/Norris Comprehensive Cancer Center, LAC-USC Medical Center, Huntington Memorial Hospital, and Childrens Hospital of Los Angeles. Her clinical expertise spans breast reconstruction, adolescent breast surgery, body contouring, complex reconstructive surgery, and aesthetic surgery, with a focus on women’s health. She founded the Adolescent Breast Center (ABC) at Childrens Hospital of Los Angeles, addressing congenital and adolescent breast disorders, and leads burn reconstruction efforts at the Southern California Regional Burn Center. Education: MD from Keck School of Medicine, followed by plastic surgery residency at USC. Teaching: Actively involved in mentoring medical students and residents. Her research interests include surgical innovations in reconstructive procedures, wound healing, and regenerative medicine. Dr. Baker’s publications reflect her contributions to breast surgery techniques, stem cell applications, and laser technology in medicine. Awards: Recognized as one of Pasadena Magazine’s Top Doctors in 2010. She collaborates with USC bariatric surgeons to offer post-weight loss body contouring and maintains affiliations across multiple top-tier medical institutions.

• Plastic and Reconstructive Surgery
• Breast Reconstruction
• Women’s Health
• +5 more

Dr. Shawn Gomez is a Professor in the Lampe Joint Department of Biomedical Engineering at UNC-Chapel Hill and North Carolina State University and in the Department of Pharmacology at UNC-Chapel Hill. He serves as the Executive Director of FastTraCS, a component of the NC TraCS Institute funded through the NIH CTSA Program, and is a UNC Lineberger Comprehensive Cancer Center member. His educational background includes a PhD in Biomedical Engineering from Columbia University (1999), an MS in Aerospace Engineering Sciences from the University of Colorado, Boulder (1993), and a BS in Aerospace Engineering Sciences from the same institution (1990). He completed postdoctoral training in Bioinformatics and Computational Biology at the Judith P. Sulzberger Columbia Genome Center and Institut Pasteur in Paris. Dr. Gomez's research spans systems biology , network pharmacology , and translational AI , with a focus on understanding cell signaling architecture in human disease. His lab develops computational approaches for network pharmacology and targeted cancer therapies, along with machine learning methodologies to address clinical needs and enhance clinical decision making. The research integrates computational modeling with experimental approaches to improve diagnostic and therapeutic interventions. His recent publications reveal a strong focus on kinome research, particularly in pancreatic cancer and understudied kinases, with increasing integration of machine learning techniques for predicting clinical outcomes and kinase-substrate relationships. The work spans from fundamental systems biology to translational applications in cancer therapeutics and surgical outcomes prediction. Scientific Awards: Leadership Advanced Program, UNC-Chapel Hill 2017 Chancellor's Entrepreneurship Boot Camp 2015 ACCLAIM Scholar (Academic Career Leadership Academy in Medicine) 2013-2014 UNC Research Council Award 2011 Carl Storm URM Fellowship 2008 UNC Junior Faculty Development Award 2006 Florence Gould Scholar 2005 Pasteur Foundation Fellow 2002-2005 Dr. Gomez directs the Gomez Lab, which focuses on systems biology, network pharmacology, and translational AI. The lab maintains several key resources including Darkkinome.org, FAAS, and IAS servers for kinome research. His work bridges computational biology with clinical applications, particularly in cancer therapeutics and surgical outcomes prediction through machine learning approaches.

• Systems Biology
• Network Pharmacology
• Translational AI
• +7 more

Dr. Stanley J. Rogers is a Professor in the Department of Surgery at the University of California, San Francisco (UCSF), School of Medicine. He holds the Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery and the His Majesty King Bhumibol Adulyadej, Rama IX Distinguished Professorship of Global Surgery. He serves as Interim Division Chief of General Surgery and directs the Bariatric Surgery Center, Liver Tumor Ablation Program, and Minimally Invasive Surgery Program. He is also a staff and trauma surgeon at Zuckerberg San Francisco General Hospital and Trauma Center, where he leads videoendoscopic surgery. University: University of California, San Francisco School: School of Medicine Department: Department of Surgery Role: Professor, Interim Division Chief, Director Email: stan.rogers@ucsf.edu Dr. Rogers' research and clinical expertise focus on minimally invasive and bariatric surgical techniques, particularly laparoscopic surgery, sleeve gastrectomy, gastric bypass, and liver tumor ablation. His work explores the metabolic and skeletal consequences of bariatric procedures, with a strong emphasis on calcium metabolism, bone health, and gut microbiome changes. He has contributed extensively to understanding complications and outcomes in gastrointestinal and metabolic surgery. His recent publications show a consistent trend in studying the long-term metabolic and skeletal impacts of bariatric surgery, particularly comparing sleeve gastrectomy and gastric bypass. Key themes include bone mineral density changes, calcium absorption, hormonal regulation (e.g., PYY), and the role of the gut microbiome. Many studies involve collaborations with endocrinologists and metabolic researchers, reflecting a multidisciplinary approach to surgical outcomes. Scientific Awards and Honors: Honorary Fellow, Royal College of Surgeons (2016) His Majesty King Bhumibol Adulyadej Rama IX Distinguished Professor of Global Surgery, UCSF (2012) Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery, UCSF (2011) Fellow, American College of Surgeons (1995) Dr. Rogers has supervised numerous residents and fellows and is actively involved in clinical training. He has served as Principal Investigator and Co-Investigator on multiple NIH-funded grants, including studies on calcium absorption, sleeve gastrectomy effects, and anti-reflux surgery. His work has significant implications for improving postoperative care and long-term outcomes in bariatric patients. He is affiliated with several key programs at UCSF, including the Bariatric Surgery Center, the Liver Tumor Ablation Program, the Minimally Invasive Surgery Program, the Comprehensive Cancer Center, and the Institute for Global Health Sciences. His leadership extends to clinical trials on endoscopic techniques and bariatric revision surgery.

• Minimally Invasive Surgery
• Bariatric Surgery
• Laparoscopic Surgery
• +7 more

Shushu Huang is an Associate Research Scientist in the Department of Genetics at Yale School of Medicine. They hold a PhD from Nanjing Medical University (2023) and an MD from the same institution (2013). Their research focuses on genetic and molecular mechanisms underlying metabolic disorders, muscular dystrophies, and cardiovascular diseases. Key areas include CRISPR-based therapeutic discovery, high-throughput functional genomics, and gene therapy safety. Huang has collaborated with researchers like Monkol Lek and Carlos Fernandez-Hernando on projects involving LXR signaling, DUX4 toxicity, and MC4R variant analysis. Publications span studies on vascular biology, gene therapy outcomes, and obesity genetics. Notable work includes investigating hypercholesterolemia’s role in vascular remodeling and analyzing MC4R variants in morbid obesity. Their lab is located in the Anlyan Center, New Haven.

• Genetics
• Molecular Biology
• Gene Therapy
• +4 more

Shaji K Chacko, Ph.D., is an Instructor in the Department of Pediatrics – Nutrition at Baylor College of Medicine, where he leads an independent research laboratory at the USDA/ARS Children's Nutrition Research Center in Houston, Texas. His work focuses on metabolic regulation, particularly glucose production pathways in health and disease. BS, Nagpur University (1990) MS, Barkatullah University (1992) MS, University of Houston, Clear Lake (2000) PhD, University of Groningen (2011) Dr. Chacko's research centers on glucose metabolism , specifically gluconeogenesis and glycogenolysis , using stable isotope tracers and mass spectrometry. His lab investigates metabolic dysfunctions in conditions such as insulin resistance, type 2 diabetes, and post-surgical states, with a strong focus on pediatric and neonatal populations. He also studies total energy expenditure using the doubly labeled water method in free-living subjects. The 15 most recent publications reflect a consistent focus on metabolic regulation, particularly in insulin resistance , obesity , diabetes , and parenteral nutrition . Key themes include hormonal regulation (e.g., leptin), amino acid metabolism (glycine, BCAA), liver function, and therapeutic interventions like metformin and nutritional supplements. His work frequently involves translational models, including human clinical studies and genetically modified animal models. Dr. Chacko has not received any explicitly mentioned scientific awards in the provided texts. He mentors lab members such as Zhensheng Chen (Research Associate) and collaborates extensively with clinicians and scientists, including M.W. Haymond and F. Jahoor. While no specific grants are listed, his research likely involves externally funded projects given the scope and equipment required for stable isotope and mass spectrometry studies. His lab benefits from the state-of-the-art facilities at the Children's Nutrition Research Center, including a metabolic kitchen, greenhouse, and advanced instrumentation. The Shaji Chacko Lab is embedded within the USDA/ARS Children's Nutrition Research Center, a multidisciplinary hub housing elite scientists conducting cutting-edge research in pediatric nutrition and metabolism. The center provides extensive resources including specialized laboratories, research accommodations, and a collaborative scientific environment.

• Glucose Metabolism
• Gluconeogenesis
• Glycogenolysis
• +12 more

Dr. Kathryn Kaiser is an Assistant Professor in the Department of Health Behavior at the University of Alabama at Birmingham (UAB) School of Public Health. She holds concurrent appointments in multiple research centers including the Center for Clinical and Translational Science and the Nutrition Obesity Research Center (NORC). Her research focuses on meta-research methodologies, race/sex disparities in obesity, systematic reviews of nutrition interventions, and advancing FAIR data principles for scientific communication. Education: B.S. Microbiology (Texas A&M), B.S. Medical Technology (University of Texas Health Science Center), Ph.D. in Health Psychology (University of North Texas Health Science Center). Postdoctoral training in Vascular Biology/Hypertension at UAB. Extensive background in medical diagnostics instrumentation and laboratory science prior to academia. Research Interests: Systematic review methodologies, FAIR data standards, obesity disparities with a focus on neuroendocrine mechanisms, and translational research in bariatric surgery outcomes. Specializes in methodological rigor for clinical trials and evidence synthesis. Grants: NIH-funded projects on FAIR principles implementation, dairy intake research, obesity energetics, and lifespan studies. Recent grants include $2.1M for metadata education programs and $1.8M for knowledge mapping initiatives. Awards: Recognized as 2015 Top Reviewer for American Journal of Preventive Medicine. Serves as Associate Editor for Frontiers in Nutrition. Active member of Cochrane Collaboration and multiple professional societies. Teaching: Graduate courses in Health Program Evaluation, Psychophysiology, and Systematic Review Design. Supervises doctoral students in health behavior research through 30+ dissertation committees since 2011. Labs/Teams: Key contributor to UAB's Nutrition Obesity Research Center (NORC) and Center for Outcomes and Effectiveness Research (COERE). Collaborates with international metadata initiatives like Metadata 2020 and science dialogue mapping projects.

• Meta-Research
• Obesity Disparities
• Systematic Reviews
• +6 more

Tiffany K. Hor, MD, is an Assistant Professor in the Department of Internal Medicine at Rush Medical College, Rush University, Chicago, IL. She is a board-certified endocrinologist with clinical expertise in diabetes, thyroid disease, pituitary disorders, and ultrasound-guided thyroid procedures. Her research focuses on clinical endocrinology, particularly diabetes management in both outpatient and inpatient settings. Key areas include insulin therapy optimization, post-bariatric hypoglycemia, and complications of thyroid interventions. Her scholarly work reflects a strong emphasis on practical clinical applications and patient safety. Dr. Hor's publications highlight trends in insulin regimens, rare endocrine complications, and innovative uses of high-concentration insulin. Her work bridges clinical practice and research to improve patient outcomes in complex endocrine disorders. Endocrinology, Diabetes and Metabolism – Board Certification She has contributed to clinical research through publications in journals such as Journal of Clinical Endocrinology & Metabolism , Thyroid , and Case Reports in Endocrinology . Her work includes clinical trials and case studies that inform evidence-based practice in endocrinology. Dr. Hor is actively involved in patient care at Rush Endocrinology, located at 1725 W. Harrison St., Suite 250, Chicago, IL. She mentors trainees and contributes to medical education at Rush Medical College. There is no information available about formal advisees or research grants.

• Endocrinology
• Diabetes
• Metabolism
• +4 more

Pixu Shi is an Assistant Professor in the Department of Biostatistics and Bioinformatics at Duke University's School of Medicine. Previously, they served as a Visiting Assistant Professor in the Department of Statistics at the University of Wisconsin-Madison (2018-2020) and as a Postdoctoral Researcher in the Department of Biostatistics at the University of Wisconsin-Madison (2016-2018). Dr. Shi earned their PhD in Biostatistics from the University of Pennsylvania in 2016 under advisor Hongzhe Li. They also hold an MS in Biostatistics from the University of Pennsylvania (2015), an MS in Statistics from Rutgers University (2012), and a BS in Statistics from Peking University (2010). Dr. Shi's research focuses on developing statistical methods for Microbiome Research, Longitudinal/Temporal Omic Data analysis, Integration of Omic Data, Spatial Omics, and High-dimensional Statistical Inference. Their work bridges statistical theory with practical applications in biomedical research, particularly in microbiome studies where they've made significant contributions with the TEMPTED (TEMPoral TEnsor Decomposition) method. The article trends show a strong focus on microbiome analysis, statistical methodology development, and applications in obesity, infectious disease, and cancer research. Their most recent work (2024-2025) demonstrates expertise in tensor decomposition methods, longitudinal data analysis, and integrating microbiome data with clinical outcomes across diverse areas including adolescent obesity, viral infections, and cancer metastases. Dr. Shi has secured multiple substantial research grants from major institutions including the National Institutes of Health (NIMH, NIAID, NCI, NIDDK, NIA), totaling over a decade of continuous funding for projects related to microbiome research, HIV/AIDS, cancer biomarkers, and metabolic studies. They actively contribute to education through teaching courses such as BIOSTAT 905: Linear Models and Inference at Duke University and previously taught statistics courses at the University of Wisconsin-Madison. Dr. Shi has also organized specialized workshop series including Quantitative Methods for HIV/AIDS, Microbiome, Immunology, and Cancer Bioinformatics.

• Microbiome Research
• Longitudinal/Temporal Omic Data
• Integration of Omic Data
• +2 more

Claudia Gunsch is the Muriel Theodorsen Williams E'46 Distinguished Professor of Civil and Environmental Engineering at Duke University, with secondary appointments in the Nicholas School of the Environment and Department of Biomedical Engineering. She directs the NSF Engineering Research Center for Precision Microbiome Engineering (PreMiEr) and serves as Associate Director for the Duke Microbiome Center. PhD (2004): University of Texas at Austin MS (2000): Clemson University BS (1998): Purdue University Her research focuses on environmental molecular biotechnology , particularly: investigating ecological impacts of emerging contaminants on microbiomes; developing microbiome engineering approaches for bioremediation; studying microbial evolution from contaminant exposure; and creating innovative water treatment technologies. Current projects apply advanced molecular methods to probe environmental microbial processes in bioremediation, contaminant impact assessment, and environmental microbiome modeling. She has been recognized with numerous awards including: NSF Faculty Early Career Development Award (2009), ASCE Huber Prize (2016), and NAE Frontiers of Engineering Fellowship (2011). Her lab has mentored 28 graduate students, 34 undergraduates, and 8 postdoctoral associates. She leads research initiatives funded by NSF, EPA, NIEHS, and industry partners. Editor-in-Chief, Biodegradation journal Member, npj Clean Water and Industrial Biotechnology editorial boards Active in AEESP and ASCE leadership roles

• Environmental Engineering
• Molecular Biotechnology
• Bioremediation
• +3 more

Andrew Bishara, MD, is an Assistant Professor in Residence in the Department of Anesthesiology within the School of Medicine at the University of California, San Francisco (UCSF). He is affiliated with multiple UCSF clinical sites, including Mission Bay, Mount Zion, and Parnassus, and is actively involved in the AI Clinical Innovation Lab, Transplant Anesthesia Research Group, and POCCO (PeriOperative Cardiac Complications Observatory). His clinical practice as an anesthesiologist is deeply integrated with his research in machine learning and artificial intelligence for perioperative care. Dr. Bishara's educational background includes a BSE in Mechanical Engineering from MIT (2009), an MD from Harvard Medical School (2014), and a D.ABA. in Anesthesiology from UCSF (2019). He also completed specialized training in Medical Informatics and Artificial Intelligence through the Bakar Computational Health Sciences Institute (2020) and a Diversity, Equity, and Inclusion Champion program at UCSF (2022). His research focuses on developing and validating machine learning models to predict and prevent surgical complications such as acute kidney injury, postoperative delirium, pain, and blood loss in real time. He emphasizes creating clinically usable models and improving AI-human interfaces for seamless integration into clinical workflows. His work also explores gender-based disparities in coronary artery disease diagnosis using EHR data analytics. His recent publications demonstrate expertise in AI quality improvement, model implementation in acute care, and predictive modeling across diverse surgical and critical care domains. He co-founded Bezel Health, a company focused on healthcare quality measurement, reflecting his commitment to translating research into real-world impact. Clinical Artificial Intelligence Quality Improvement Real-time Risk Assessment in Surgery AI Integration in Anesthesia Gender Disparities in Cardiac Care Transplant Anesthesia Research Regulatory Aspects of AI in Medicine Dr. Bishara is actively engaged in advancing perioperative medicine through innovation in data science and AI, with a strong emphasis on improving patient outcomes, equity, and clinical workflow efficiency.

• Machine Learning in Healthcare
• Artificial Intelligence in Clinical Decision Support
• Perioperative Medicine
• +12 more

Andrew C. Shin is an Assistant Professor at Texas Tech University within the Department of Nutritional Sciences . His work bridges metabolic health , neuroendocrinology , and neurodegenerative diseases , with a focus on how the brain regulates glucose homeostasis , BCAA metabolism , and bariatric surgery mechanisms . Ph.D. in Neuroscience, Michigan State University (2008) Postdoctoral Fellow, Pennington Biomedical Research Center and Icahn School of Medicine at Mount Sinai Dr. Shin’s research explores the neural pathways involved in appetite regulation , nutrient partitioning , and metabolic resistance . His NIH-funded projects investigate insulin signaling in POMC neurons , BCAA dynamics , and nicotine’s metabolic effects . Recent work highlights the role of the autonomic nervous system in BCAA regulation and its implications for obesity and diabetes . His 15 most recent publications reflect a focus on AI applications in nutrition , BCAA-related pathologies , Alzheimer’s disease , and metabolic surgery outcomes . Key themes include neuroendocrine control , nutritional interventions , and environmental impacts on metabolism . Scientific Awards NIH K01 Award Dr. Shin directs the Mouse Metabolic Phenotyping Facility and collaborates on synbiotic trials for cognitive aging . His work spans basic science and translational research , addressing metabolic disorders and their neurological consequences .

• Metabolic Health
• Neuroendocrinology
• Branched-Chain Amino Acid (BCAA) Metabolism
• +5 more

Kunihiro Matsushita, MD, PhD is a Professor at Johns Hopkins University with dual appointments at the Bloomberg School of Public Health and School of Medicine. He holds a primary affiliation with the Department of Epidemiology, specifically within the Cardiovascular and Clinical Epidemiology division. Dr. Matsushita also maintains significant affiliations with the Welch Center for Prevention, Epidemiology and Clinical Research and serves as Director of the Data Coordinating Center for the Chronic Kidney Disease Prognosis Consortium (CKD-PC), which comprises over 70 cohorts totaling approximately 11 million individuals worldwide. Dr. Matsushita earned his MD in 1998 and PhD in 2007, both from Nagoya University in Japan. His academic journey began with clinical experience as an interventional cardiologist, which shaped his early research interests in diabetes as a key risk factor for coronary heart disease and its antecedent, obesity. Since joining Johns Hopkins, he has expanded his research to include kidney-related aspects, particularly investigating the complex associations among kidney disease, diabetes, and cardiovascular disease using the Atherosclerosis Risk in Communities (ARIC) Study and the CKD Prognosis Consortium. Dr. Matsushita's research program focuses on bridging medicine and epidemiological research to establish evidence that can improve treatment and prevention of cardiovascular and kidney diseases. His work spans multiple areas including cardiovascular epidemiology, chronic kidney disease prognosis, peripheral artery disease, hypertension, diabetes complications, and risk prediction modeling. He has made significant contributions to understanding how kidney function metrics relate to cardiovascular outcomes across diverse populations. Analysis of Dr. Matsushita's recent publications reveals a strong focus on the intersection of kidney and cardiovascular disease. His research employs large-scale meta-analyses of individual participant data across multiple international cohorts, with particular emphasis on glomerular filtration rate, albuminuria, and their relationship to cardiovascular outcomes. Recent work has expanded into novel areas including arterial stiffness, artificial intelligence applications in kidney disease management, and the impact of modifiable risk factors like smoking and dietary protein on kidney and cardiovascular health. Honors & Awards: American College of Physician Membership (2005) Research Fellow of the Japan Society for the Promotion of Science (2007) Best Reviewers of the Year 2012 of the Annals of Internal Medicine (2013) Japanese Society of Interventional Cardiology Clinical Research Award (2004) Aichi Foundation for Diabetes, Rheumatic Disease and Gout Research Grant (2005) Takao Fund Travel Award (2006) Early Career Travel Award from the American Heart Association (2009) The Aoyama-Kita Scholarship, Johns Hopkins Bloomberg School of Public Health (2009) Early Career Best Science Award at AHA Scientific Sessions (2013) The Sandra Daugherty Award for Excellence in Cardiovascular Disease Epidemiology (2014) Golden Apple Award for Teaching from JHSPH (2019) Dr. Matsushita's leadership extends to major collaborative projects including the Chronic Renal Insufficiency Cohort (CRIC) Study, research on weight loss with bariatric surgery and vascular changes, and national trend analyses of critical limb ischemia hospitalizations. His work with the CKD Prognosis Consortium represents one of the largest international collaborative efforts in kidney disease epidemiology, providing critical evidence for clinical guidelines worldwide.

• epidemiology
• cardiovascular disease
• peripheral artery disease
• +6 more

Rosario B. Jaime-Lara is an Assistant Professor at the University of California, Los Angeles (UCLA) School of Nursing. She holds advanced degrees including a PhD in Nursing from the University of Pennsylvania, MSN from Columbia University, and dual BS degrees in Nursing and Biological Sciences from University of Pennsylvania and UC Davis. Her research focuses on neurophysiological mechanisms of eating behavior, nutritional disparities in Mexican-American communities, and chemosensory science. Key themes include obesity research, sensory neuroscience, and translational clinical studies. She employs rodent models and clinical research methodologies to explore taste/smell physiology and metabolic health. Jaime-Lara has received over 17 honors including the 2022 Hommer Memorial Award and multiple diversity fellowships. Her work spans interdisciplinary collaborations in genomics, microbiome research, and health IT interventions for chronic disease management. Recent publications emphasize olfactory dysfunction in coronaviruses, fat taste mediators, and metabolic profiling. Her research bridges basic science and clinical practice, with particular attention to underserved populations.

• Nutrition
• Neurophysiology
• Obesity Research
• +5 more

Todd Williams is a Professor in the Department of Psychology at Grand Valley State University within the College of Liberal Arts and Sciences. He earned his B.A. and Ph.D. (2009) from the University of Alberta, Canada. As co-director of the GVSU Social Cognition Laboratory, his research focuses on metacognition, Machiavellianism, and animal welfare. Education: B.A. & Ph.D. in Psychology, University of Alberta Research interests span three primary areas: Metacognition of belief change during learning Machiavellianism as a multidimensional personality construct Quantitative approaches to animal welfare assessment His recent publications demonstrate interdisciplinary connections between cognitive psychology, personality theory, and health sciences. In teaching, he specializes in foundational courses including: PSY 101 - Introductory Psychology PSY 300 - Research Methods PSY 360 - Social Psychology PSY 400 - Advanced Research PSY 492 - Capstone Contact: Office 2313 Au Sable Hall | Phone (616) 331-8976

• Social Psychology
• Social Cognition
• Metacognition
• +3 more

Erika Garcia, PhD, MPH is an Assistant Professor in the Division of Environmental Health at the Department of Population and Public Health Sciences, Keck School of Medicine of USC. Her work focuses on understanding how ambient environmental exposures influence human disease development, particularly through advanced causal inference methods. Key research areas include early-life air pollution effects on pediatric health (asthma, lung function, metabolic outcomes) and climate-driven exposures like extreme heat. Education: PhD in Environmental Health Sciences, UC Berkeley MPH in Environmental Health Sciences, UC Berkeley Research Interests: Climate change health impacts: heat waves, air pollution, and associated mortality/morbidity Environmental justice: disparities in pollution exposure and health outcomes Exposure mixtures: synergistic effects of chemical pollutants Epigenetic biomarkers of environmental exposures Recent Article Trends: Focus on methodological innovations in exposure assessment, policy-driven intervention modeling, and translational research linking environmental exposures to chronic disease pathways. Recent work emphasizes population-level vulnerability analysis and actionable solutions for disadvantaged communities. Advising/Grants: Active in mentoring interdisciplinary teams but specific grant details not highlighted in current text.

• Environmental Health
• Epidemiology
• Climate Change Health Impacts
• +4 more